NCT03952299View on ClinicalTrials.gov

Oxybutynin for Post-surgical Bladder Pain and Urgency

PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Overactive Bladder SyndromeNeuropathic Bladder
Interventions
DRUG

Oxybutynin Transdermal Patch

Transdermal patch of oxybutynin will be used instead of oral oxybutynin.

DRUG

Oral Oxybutynin

Oral administration of oxybutynin (5mg) every 8 hours in the hospital.

Trial Locations (1)

95817

RECRUITING

University of California Davis Medical Center (UCDMC), Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER